TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme

Evaluation consultancy services
Wales (UKL22)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership: "Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Wales Shared Services PartnershipScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
7.5Bids / Report
50% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 2 active published awards; 2 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Wales Shared Services Partnership
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published13 Jun 2024, 11:35 BST
Last source update13 Jun 2024, 11:35 BST
Recurring procurementNot published
ClassificationEvaluation consultancy services
Delivery area
Wales (UKL22)
OCIDocds-h6vhtk-03d605
What is being bought
NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: · To review, develop and publish the National Optimal Pathways. · In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. · Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). · Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. · Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: · To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: · To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. · To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways
What changed
From the official release history
  1. tender value changed
    13 Jun 2024, 11:35 BST
  2. Status changed to complete
    13 Jun 2024, 11:35 BST
  3. Official notice release published
    13 Jun 2024, 11:35 BST
  4. Submission deadline changed to published date
    13 Jun 2024, 11:35 BST
  5. Published value updated to £100,000
    14 Jun 2023, 11:08 BST
  6. Status changed to active
    14 Jun 2023, 11:08 BST
  7. Official notice release published
    14 Jun 2023, 11:08 BST
  8. Submission deadline changed to 4 Jul 2023, 12:00 BST
    14 Jun 2023, 11:08 BST
  9. Buyer information updated
    14 Jun 2023, 11:08 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: · To review, develop and publish the National Optimal Pathways. · In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. · Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). · Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. · Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: · To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: · To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. · To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    13 Jun 2024, 11:35 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 18 Dec 2023, 00:00 GMT · £99,920
Commercial outcome and competition
Awards
Carnall Farrar
Not published · Not published · active
Contracts
Contract
£99,920 · signed 18 Dec 2023, 00:00 GMT · active
Bid statistics
bids: 14 (lot 1)
electronicBids: 14 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 6 (lot 1)
Buyer and organisations in this procedure

NHS Wales Shared Services Partnership

Contracting authority GB-FTS-37740
View buyer profile

  • NHS Wales Shared Services Partnership
    buyer
    centralPurchasingBody

    2nd Floor Woodland House, Maes-y-Coed Road, Cardiff, UK, CF14 4TT
    Owen.rees3@wales.nhs.uk
    +44 2921508271

  • Carnall Farrar
    supplier

    91 Wimpole Street, London, UK, W1G0EF
    +44 2037707536

  • High Court
    reviewBody

    Royal Courts of Justice, The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published